Jang J - Search Results

1

Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.

Jang J, Kim HK, Cho BC, Lee KH, Yun HJ, Woo IS, Song HS, Ryoo HM, Kim CH, Sun DS, Shin JW. Jang J, et al. Cancer Chemother Pharmacol. 2017 May;79(5):873-880. doi: 10.1007/s00280-017-3289-6. Epub 2017 Mar 24. Cancer Chemother Pharmacol. 2017. PMID: 28341958 Clinical Trial.

2

Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma.

Lee GW, Kang JH, Kim HG, Lee JS, Lee JS, Jang JS. Lee GW, et al. Am J Clin Oncol. 2006 Apr;29(2):127-31. doi: 10.1097/01.coc.0000203742.22828.bb. Am J Clin Oncol. 2006. PMID: 16601429 Clinical Trial.

3

Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.

Park JO, Kim SW, Ahn JS, Suh C, Lee JS, Jang JS, Cho EK, Yang SH, Choi JH, Heo DS, Park SY, Shin SW, Ahn MJ, Lee JS, Yun YH, Lee JW, Park K. Park JO, et al. J Clin Oncol. 2007 Nov 20;25(33):5233-9. doi: 10.1200/JCO.2007.10.8134. J Clin Oncol. 2007. PMID: 18024869 Clinical Trial.

4

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

Jang JS, Lim HY, Hwang IG, Song HS, Yoo N, Yoon S, Kim YH, Park E, Byun JH, Lee MA, Oh SJ, Lee KH, Kim BS, Oh SC, Kim SY, Lee SJ. Jang JS, et al. Cancer Chemother Pharmacol. 2010 Mar;65(4):641-7. doi: 10.1007/s00280-009-1069-7. Epub 2009 Aug 4. Cancer Chemother Pharmacol. 2010. PMID: 19652971 Clinical Trial.

5

A phase II study of leucovorin, 5-FU and docetaxel combination chemotherapy in patients with inoperable or postoperative relapsed gastric cancer.

Lee KS, Lee HY, Park EK, Jang JS, Lee SJ. Lee KS, et al. Cancer Res Treat. 2008 Mar;40(1):11-5. doi: 10.4143/crt.2008.40.1.11. Epub 2008 Mar 31. Cancer Res Treat. 2008. PMID: 19688059 Free PMC article.

6

Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness.

Oh SY, Jeong CY, Hong SC, Kim TH, Ha CY, Kim HJ, Lee GW, Hwang IG, Jang JS, Kwon HC, Kang JH. Oh SY, et al. Invest New Drugs. 2011 Oct;29(5):1066-72. doi: 10.1007/s10637-010-9417-3. Epub 2010 Apr 1. Invest New Drugs. 2011. PMID: 20358256 Clinical Trial.

7

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, Shin DB, Kang HJ, Sun JM, Park JO, Park YS, Kang WK, Lim HY. Lee J, et al. Among authors: jang js. Lancet Oncol. 2012 Feb;13(2):181-8. doi: 10.1016/S1470-2045(11)70301-1. Epub 2011 Dec 20. Lancet Oncol. 2012. PMID: 22192731 Clinical Trial.

8

A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer.

Hwang IG, Jang JS, Oh SY, Lee S, Kwon HC, Lee GW, Go S, Kang MH, Cha YJ, Kang JH. Hwang IG, et al. Invest New Drugs. 2012 Dec;30(6):2371-6. doi: 10.1007/s10637-012-9792-z. Invest New Drugs. 2012. PMID: 22302349 Clinical Trial.

9

A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01).

Ji JH; Korean Cancer Study Group (KCSG); Yun T, Kim SB, Kang JH, Park JC, Cho IS, Sohn CH, Heo DS, Jang JS, Shin SW, Hwang DW, Sun JM, Park K, Ahn MJ. Ji JH, et al. Eur J Cancer. 2012 Nov;48(17):3198-204. doi: 10.1016/j.ejca.2012.06.009. Epub 2012 Jul 13. Eur J Cancer. 2012. PMID: 22795584 Clinical Trial.

10

Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysis.

Hwang IG, Song HS, Lee MA, Nam EM, Lim J, Lee KH, Lee KT, Zang DY, Jang JS. Hwang IG, et al. Among authors: jang js. Cancer Chemother Pharmacol. 2014 Dec;74(6):1291-6. doi: 10.1007/s00280-014-2608-4. Epub 2014 Oct 18. Cancer Chemother Pharmacol. 2014. PMID: 25326056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,112 results

Search Page

Filters